Nicox resubmits AC-170 (ZERVIATE) NDA to the U.S. FDA

Go back to Nicox resubmits AC-170 (ZERVIATE) NDA to the U.S. FDA
(NYSE: COX) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $ 
Volume 0